Share Price and Basic Stock Data
Last Updated: January 2, 2026, 10:05 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Agrigenetics Ltd operates in the floriculture industry, with a current market price of ₹54.3 and a market capitalization of ₹23.9 Cr. The company reported sales figures that have shown volatility over the past quarters. For instance, the sales for June 2023 and December 2023 were ₹0.04 Cr and ₹0.03 Cr respectively, while sales for September 2023 stood at ₹0.00 Cr, indicating a significant fluctuation in revenue streams. Over the past fiscal years, sales reported for FY 2024 were ₹0.07 Cr, slightly up from ₹0.06 Cr in FY 2023. However, the trailing twelve months (TTM) sales also stood at ₹0.07 Cr, reflecting a stagnant revenue trend. Given the company’s operational challenges, it is crucial to monitor upcoming quarterly results for any signs of consistent revenue recovery or growth.
Profitability and Efficiency Metrics
The profitability metrics for Hindustan Agrigenetics Ltd indicate persistent challenges. The company reported an operating profit margin (OPM) of -250% for June 2025, a stark contrast to an OPM of 25% in June 2023, highlighting significant operational inefficiencies. The net profit for March 2025 was recorded at ₹-0.69 Cr, down from ₹1.07 Cr in March 2024, showing a negative trend in profitability. The return on equity (ROE) stood at a mere 3.61%, while the return on capital employed (ROCE) was slightly lower at 3.53%. The interest coverage ratio (ICR) of -23.78x further underscores the financial strain, as it indicates that the company is unable to cover its interest obligations. These figures reflect a critical need for improved cost management and operational efficiency to enhance profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindustan Agrigenetics Ltd shows a relatively stable position with no borrowings reported, which is a positive aspect. The company recorded reserves of ₹8.21 Cr as of September 2025, reflecting a gradual increase from ₹7.46 Cr in March 2023. The price-to-book value (P/BV) ratio stood at 2.49x, suggesting that the stock may be overvalued compared to its book value of ₹26.95 per share reported in March 2025. The company enjoys a high current ratio of 330.73, indicating excellent short-term liquidity. However, the negative operating profit margins and a declining trend in profitability metrics raise concerns about the sustainability of this position. Overall, while the lack of debt is a strength, the company’s operational inefficiencies pose risks to its financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Agrigenetics Ltd reflects a diverse ownership structure, with promoters holding 25.35% as of September 2025, a decline from 29.42% in December 2022. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minimal stakes of 0.43% and 1.08%, respectively, indicating limited institutional interest. The public holds a significant 64.71% stake, suggesting a broad retail investor base. The total number of shareholders has increased to 7,669, up from 5,732 in December 2022, indicating growing interest. However, the declining promoter stake might raise concerns about management confidence in the company’s future prospects. This shift in ownership dynamics could influence investor sentiment and market perception.
Outlook, Risks, and Final Insight
The outlook for Hindustan Agrigenetics Ltd remains uncertain, primarily due to ongoing profitability issues and fluctuating sales figures. The company’s lack of debt is a notable strength, providing some cushion against economic downturns. However, the persistent negative operating margins, coupled with a declining trend in profitability and shareholder confidence, present significant risks. Key strengths include its robust liquidity position and a growing shareholder base. Conversely, operational inefficiencies and weak institutional interest could hinder its recovery efforts. The company must focus on cost management and operational improvements to enhance its profitability. If it successfully addresses these issues, it may pave the way for a more stable financial future, but failure to do so could lead to further declines in investor confidence and market performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Nagarjuna Agri Tech Ltd | 44.8 Cr. | 47.8 | 83.3/34.8 | 82.9 | 7.73 | 0.00 % | 1.34 % | 1.34 % | 10.0 |
| Hindustan Agrigenetics Ltd | 23.9 Cr. | 54.3 | 103/48.0 | 265 | 0.00 % | 3.53 % | 3.61 % | 10.0 | |
| Elegant Floriculture & Agrotech (India) Ltd | 9.50 Cr. | 4.75 | 11.6/4.38 | 3.08 | 12.8 | 0.00 % | 5.85 % | 5.22 % | 10.0 |
| Industry Average | 0 Cr | 35.62 | 116.99 | 10.27 | 0.00% | 3.57% | 3.39% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 | 0.00 | 0.03 | 0.00 | 0.04 |
| Expenses | 0.33 | 0.05 | 0.11 | 0.12 | 0.03 | 0.07 | -0.06 | 0.01 | 0.01 | 0.00 | 0.24 | 0.69 | 0.14 |
| Operating Profit | -0.29 | -0.05 | -0.08 | -0.12 | 0.01 | -0.07 | 0.09 | -0.01 | 0.03 | 0.00 | -0.21 | -0.69 | -0.10 |
| OPM % | -725.00% | -266.67% | 25.00% | 300.00% | 75.00% | -700.00% | -250.00% | ||||||
| Other Income | 0.09 | 0.14 | 0.15 | 0.03 | 0.14 | 0.16 | 0.15 | 0.15 | 0.02 | 0.15 | 0.24 | 0.18 | 0.51 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.08 | 0.23 | 0.13 | 0.04 | 0.14 | 0.02 | -0.52 | 0.40 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.20 | 0.09 | 0.07 | -0.09 | 0.15 | 0.07 | 0.22 | 0.13 | 0.04 | 0.14 | 0.02 | -0.52 | 0.40 |
| EPS in Rs |
Last Updated: August 19, 2025, 1:50 pm
Below is a detailed analysis of the quarterly data for Hindustan Agrigenetics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.04 Cr..
- For Expenses, as of Jun 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.69 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.55 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.10 Cr.. The value appears strong and on an upward trend. It has increased from -0.69 Cr. (Mar 2025) to -0.10 Cr., marking an increase of 0.59 Cr..
- For OPM %, as of Jun 2025, the value is -250.00%. The value appears to be declining and may need further review. It has decreased from 0.00% (Mar 2025) to -250.00%, marking a decrease of 250.00%.
- For Other Income, as of Jun 2025, the value is 0.51 Cr.. The value appears strong and on an upward trend. It has increased from 0.18 Cr. (Mar 2025) to 0.51 Cr., marking an increase of 0.33 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.92 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Net Profit, as of Jun 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from -0.52 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.92 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.00. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 | 0.19 | 0.06 | 0.06 | 0.07 | 0.07 | 0.08 | 0.07 |
| Expenses | 0.12 | 0.26 | 0.12 | 0.16 | 0.21 | 0.22 | 0.59 | 0.19 | 0.23 | 0.71 | 0.37 | 1.10 | 1.12 |
| Operating Profit | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.64 | -0.30 | -1.02 | -1.05 |
| OPM % | -100.00% | -333.33% | -100.00% | -166.67% | -320.00% | -266.67% | -210.53% | -216.67% | -283.33% | -914.29% | -428.57% | -1,275.00% | -1,500.00% |
| Other Income | 0.05 | 0.30 | 0.95 | 0.28 | 0.19 | 0.04 | 0.04 | -0.05 | 0.06 | 10.55 | 0.96 | 0.76 | 1.18 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 |
| Depreciation | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.04 |
| Profit before tax | -0.03 | 0.09 | 0.88 | 0.17 | 0.02 | -0.13 | -0.37 | -0.18 | -0.11 | 9.91 | 0.60 | -0.31 | 0.09 |
| Tax % | 133.33% | 0.00% | 25.00% | 35.29% | 3,100.00% | -7.69% | -186.49% | -16.67% | -9.09% | 0.50% | 23.33% | 0.00% | |
| Net Profit | -0.07 | 0.09 | 0.66 | 0.11 | -0.59 | -0.12 | 0.33 | -0.15 | -0.10 | 9.86 | 0.47 | -0.31 | 0.09 |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 228.57% | 633.33% | -83.33% | -636.36% | 79.66% | 375.00% | -145.45% | 33.33% | 9960.00% | -95.23% | -165.96% |
| Change in YoY Net Profit Growth (%) | 0.00% | 404.76% | -716.67% | -553.03% | 716.02% | 295.34% | -520.45% | 178.79% | 9926.67% | -10055.23% | -70.72% |
Hindustan Agrigenetics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 |
| Reserves | -2.44 | -2.35 | -1.69 | -1.63 | -2.22 | -2.48 | -2.16 | -2.30 | -2.40 | 7.46 | 7.93 | 7.62 | 8.21 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.98 | 1.01 | 0.23 | 0.15 | 0.16 | 0.22 | 0.28 | 0.85 | 6.19 | 0.50 | 0.42 | 0.38 | 0.39 |
| Total Liabilities | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.40 | 13.00 |
| Fixed Assets | 0.36 | 0.36 | 0.35 | 0.34 | 0.35 | 0.36 | 0.36 | 0.35 | 0.35 | 0.05 | 0.19 | 0.16 | 0.15 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.35 | 1.45 | 1.57 | 1.58 | 1.59 | 1.38 | 0.21 | 1.35 | 1.75 | 0.85 | 1.97 | 3.64 | 3.96 |
| Other Assets | 1.23 | 1.25 | 1.02 | 1.00 | 0.40 | 0.40 | 1.95 | 1.25 | 6.09 | 11.46 | 10.59 | 8.60 | 8.89 |
| Total Assets | 2.94 | 3.06 | 2.94 | 2.92 | 2.34 | 2.14 | 2.52 | 2.95 | 8.19 | 12.36 | 12.75 | 12.40 | 13.00 |
Below is a detailed analysis of the balance sheet data for Hindustan Agrigenetics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.40 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.40 Cr..
- For Reserves, as of Sep 2025, the value is 8.21 Cr.. The value appears strong and on an upward trend. It has increased from 7.62 Cr. (Mar 2025) to 8.21 Cr., marking an increase of 0.59 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.38 Cr. (Mar 2025) to 0.39 Cr., marking an increase of 0.01 Cr..
- For Total Liabilities, as of Sep 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.40 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 0.60 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.01 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 3.96 Cr.. The value appears strong and on an upward trend. It has increased from 3.64 Cr. (Mar 2025) to 3.96 Cr., marking an increase of 0.32 Cr..
- For Other Assets, as of Sep 2025, the value is 8.89 Cr.. The value appears strong and on an upward trend. It has increased from 8.60 Cr. (Mar 2025) to 8.89 Cr., marking an increase of 0.29 Cr..
- For Total Assets, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.40 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 0.60 Cr..
Notably, the Reserves (8.21 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.06 | -0.20 | -0.06 | -0.10 | -0.16 | -0.16 | -0.40 | -0.13 | -0.17 | -0.64 | -0.30 | -1.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | -5,170.83 | -5,353.33 | -730.00 | -243.33 | -365.00 | -608.33 | 883.68 | -4,501.67 | -36,925.83 | -1,668.57 | 730.00 | 11,543.12 |
| ROCE % | -3.51% | -2.00% | 33.61% | 0.00% | 0.81% | -1.95% | -13.46% | -5.99% | -7.80% | 144.88% | 2.07% | -3.53% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Diluted EPS (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| Cash EPS (Rs.) | -0.61 | 1.15 | 22.41 | -0.21 | -0.32 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 26.95 | 27.65 | 26.58 | 4.17 | 4.39 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 27.32 | 28.02 | 26.95 | 4.55 | 4.77 |
| Revenue From Operations / Share (Rs.) | 1.90 | 2.35 | 24.43 | 0.28 | 0.13 |
| PBDIT / Share (Rs.) | -0.59 | 1.46 | 22.52 | -0.24 | -0.40 |
| PBIT / Share (Rs.) | -0.68 | 1.38 | 22.52 | -0.25 | -0.40 |
| PBT / Share (Rs.) | -0.69 | 1.38 | 22.52 | -0.25 | -0.40 |
| Net Profit / Share (Rs.) | -0.69 | 1.07 | 22.40 | -0.22 | -0.33 |
| PBDIT Margin (%) | -31.54 | 62.20 | 92.19 | -85.45 | -288.85 |
| PBIT Margin (%) | -35.83 | 58.64 | 92.17 | -87.40 | -295.28 |
| PBT Margin (%) | -36.76 | 58.64 | 92.17 | -87.40 | -295.28 |
| Net Profit Margin (%) | -36.45 | 45.44 | 91.71 | -76.62 | -238.42 |
| Return on Networth / Equity (%) | -2.57 | 3.85 | 84.29 | -5.28 | -7.52 |
| Return on Capital Employeed (%) | -2.42 | 4.91 | 83.54 | -5.53 | -8.59 |
| Return On Assets (%) | -2.45 | 3.68 | 79.74 | -1.18 | -4.94 |
| Asset Turnover Ratio (%) | 0.06 | 0.08 | 1.05 | 0.02 | 0.02 |
| Current Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Quick Ratio (X) | 330.73 | 27.72 | 22.40 | 1.11 | 1.92 |
| Interest Coverage Ratio (X) | -23.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | -26.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 24.41 | 13.01 | -8.02 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 29.16 | 12.59 | -0.74 | 0.00 | 0.00 |
| EV / EBITDA (X) | -92.45 | 20.24 | -0.80 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 35.30 | 21.77 | 0.20 | 0.00 | 0.00 |
| Price / BV (X) | 2.49 | 1.85 | 0.19 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 35.30 | 21.77 | 0.20 | 0.00 | 0.00 |
| EarningsYield | -0.01 | 0.02 | 4.44 | 0.00 | 0.00 |
After reviewing the key financial ratios for Hindustan Agrigenetics Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 5. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.61. This value is below the healthy minimum of 3. It has decreased from 1.15 (Mar 24) to -0.61, marking a decrease of 1.76.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 26.95. It has decreased from 27.65 (Mar 24) to 26.95, marking a decrease of 0.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 27.32. It has decreased from 28.02 (Mar 24) to 27.32, marking a decrease of 0.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1.90. It has decreased from 2.35 (Mar 24) to 1.90, marking a decrease of 0.45.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.59. This value is below the healthy minimum of 2. It has decreased from 1.46 (Mar 24) to -0.59, marking a decrease of 2.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.68. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.68, marking a decrease of 2.06.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 0. It has decreased from 1.38 (Mar 24) to -0.69, marking a decrease of 2.07.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.69. This value is below the healthy minimum of 2. It has decreased from 1.07 (Mar 24) to -0.69, marking a decrease of 1.76.
- For PBDIT Margin (%), as of Mar 25, the value is -31.54. This value is below the healthy minimum of 10. It has decreased from 62.20 (Mar 24) to -31.54, marking a decrease of 93.74.
- For PBIT Margin (%), as of Mar 25, the value is -35.83. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -35.83, marking a decrease of 94.47.
- For PBT Margin (%), as of Mar 25, the value is -36.76. This value is below the healthy minimum of 10. It has decreased from 58.64 (Mar 24) to -36.76, marking a decrease of 95.40.
- For Net Profit Margin (%), as of Mar 25, the value is -36.45. This value is below the healthy minimum of 5. It has decreased from 45.44 (Mar 24) to -36.45, marking a decrease of 81.89.
- For Return on Networth / Equity (%), as of Mar 25, the value is -2.57. This value is below the healthy minimum of 15. It has decreased from 3.85 (Mar 24) to -2.57, marking a decrease of 6.42.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.42. This value is below the healthy minimum of 10. It has decreased from 4.91 (Mar 24) to -2.42, marking a decrease of 7.33.
- For Return On Assets (%), as of Mar 25, the value is -2.45. This value is below the healthy minimum of 5. It has decreased from 3.68 (Mar 24) to -2.45, marking a decrease of 6.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.06. It has decreased from 0.08 (Mar 24) to 0.06, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 3. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Quick Ratio (X), as of Mar 25, the value is 330.73. This value exceeds the healthy maximum of 2. It has increased from 27.72 (Mar 24) to 330.73, marking an increase of 303.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -23.78. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -23.78, marking a decrease of 23.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -26.78. This value is below the healthy minimum of 3. It has decreased from 0.00 (Mar 24) to -26.78, marking a decrease of 26.78.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.41. It has increased from 13.01 (Mar 24) to 24.41, marking an increase of 11.40.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 29.16. This value exceeds the healthy maximum of 3. It has increased from 12.59 (Mar 24) to 29.16, marking an increase of 16.57.
- For EV / EBITDA (X), as of Mar 25, the value is -92.45. This value is below the healthy minimum of 5. It has decreased from 20.24 (Mar 24) to -92.45, marking a decrease of 112.69.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 35.30. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 35.30, marking an increase of 13.53.
- For Price / BV (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 2.49, marking an increase of 0.64.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 35.30. This value exceeds the healthy maximum of 3. It has increased from 21.77 (Mar 24) to 35.30, marking an increase of 13.53.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to -0.01, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Agrigenetics Ltd:
- Net Profit Margin: -36.45%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.42% (Industry Average ROCE: 3.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -2.57% (Industry Average ROE: 3.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -26.78
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 330.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 265 (Industry average Stock P/E: 116.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -36.45%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Floriculture | 806, Meghdoot, 94, Nehru Place, New Delhi Delhi 110019 | hindustanagrigenetics@gmail.com http://www.hindustanagrigenetics.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pranav Kapur | Chairman |
| Mr. Pritam Kapur | Director |
| Ms. Chandni Kapur | Director & CFO |
| Ms. Mannu Kohli | Director |
| Mr. Sunny Srivastava | Independent Director |
| Mr. Naren Parsai | Independent Director |
| Mr. Ravi Shankar Kolathur | Independent Director |
FAQ
What is the latest intrinsic value of Hindustan Agrigenetics Ltd?
The latest intrinsic value of Hindustan Agrigenetics Ltd is ₹0.00. Unfortunately, additional data is unavailable.
What is the Market Cap of Hindustan Agrigenetics Ltd?
The Market Cap of Hindustan Agrigenetics Ltd is 23.9 Cr..
What is the current Stock Price of Hindustan Agrigenetics Ltd as on 04 January 2026?
The current stock price of Hindustan Agrigenetics Ltd as on 04 January 2026 is ₹54.3.
What is the High / Low of Hindustan Agrigenetics Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Agrigenetics Ltd stocks is ₹103/48.0.
What is the Stock P/E of Hindustan Agrigenetics Ltd?
The Stock P/E of Hindustan Agrigenetics Ltd is 265.
What is the Book Value of Hindustan Agrigenetics Ltd?
The Book Value of Hindustan Agrigenetics Ltd is .
What is the Dividend Yield of Hindustan Agrigenetics Ltd?
The Dividend Yield of Hindustan Agrigenetics Ltd is 0.00 %.
What is the ROCE of Hindustan Agrigenetics Ltd?
The ROCE of Hindustan Agrigenetics Ltd is 3.53 %.
What is the ROE of Hindustan Agrigenetics Ltd?
The ROE of Hindustan Agrigenetics Ltd is 3.61 %.
What is the Face Value of Hindustan Agrigenetics Ltd?
The Face Value of Hindustan Agrigenetics Ltd is 10.0.